Research Triangle Park, NC, United States of America

Tona Gilmer

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Tona Gilmer: Innovator in Cancer Treatment

Introduction

Tona Gilmer is a notable inventor based in Research Triangle Park, NC (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, his work focuses on developing pharmaceutical combinations that target cancer effectively.

Latest Patents

One of Tona Gilmer's latest patents is a method for treating cancer that involves a combination of an inhibitor of B-Raf and an inhibitor of AKT. This invention details a method of administering specific compounds to humans in need of cancer treatment. Another significant patent involves the combination of lapatinib and trametinib, which also aims to provide an effective treatment method for cancer patients. This patent outlines the administration of particular pharmaceutical compounds to enhance treatment efficacy.

Career Highlights

Throughout his career, Tona Gilmer has worked with prominent companies in the pharmaceutical industry, including Novartis AG and GlaxoSmithKline LLC. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.

Collaborations

Tona has collaborated with several professionals in his field, including Rakesh Kumar and Melissa Dumble, who is a woman. These collaborations have likely enriched his research and development efforts in cancer treatment.

Conclusion

Tona Gilmer's contributions to cancer treatment through his patents and collaborations highlight his role as an innovator in the pharmaceutical industry. His work continues to impact the lives of those affected by cancer, showcasing the importance of innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…